Research keywords (5):
Drug delivery system
, Bifidobacterium
, Anti-tumor medicine
, Pharmaceutical English
, 薬学教育
Research theme for competitive and other funds (7):
2025 - 2028 Application of Recombinant Bifidobacterium DDS Technology for Improving the Safety and Efficacy of IL Formulations
2021 - 2024 抗Ras抗体分泌ビフィズス菌を用いた新規癌治療法の開発
2019 - 2023 The development of the drug delivery system via recombinant bifidobacteria aiming for an anti-cancer TNF-alpha preparation without adverse side effects.
2018 - 2021 The application of the drug delivery system by recombinant bifidobacteria to overcome the weak point of the low-molecule anticancer STAT3 inhibitors.
2015 - 2019 Development of the novel therapy against pancreatic cancer using highly absorbable curcumin preparation and recombinant bifidobacteria.
2014 - 2019 医薬品リバイバル技術による創薬イノベーション
2008 - 2009 The analyses of the function of the axon guidance molecules in the filial imprinting of chick
Show all
Papers (30):
Yoshimi Shimizu, Katsuhiro Isoda, Kaho Shinohara, Miki Nakayama, Ikuko Taira, Yuichiro Taira. Potential Anti-Cancer Therapeutic Agents: Effects of VHH Antibodies on Mesothelin Binding Affinity in Cancer. BPB Reports. 2024. 7